Pierre d'Epenoux

Pierre d'Epenoux has extensive work experience in various leadership roles within the healthcare sector. Pierre started their career as the Country General Manager at Merck KGaA from 1995 to 1998. Pierre then served as Director of M&A at Merck KGaA from 1998 to 2002. After that, they joined Baxter Healthcare as Senior Director of Business Development and M&A from 2002 to 2009. Pierre then moved on to Sanofi, where they held the position of VP, Head of Strategy & Business Development Europe from 2009 to 2013. Following their time at Sanofi, they became the EVP, Chief Strategy Officer at THERAVECTYS from 2013 to 2016. Currently, they are serving as the Chief Executive Officer at Imcheck Therapeutics since December 2016. Throughout their career, Pierre has been involved in strategic analysis, M&A activities, and operational integration, contributing to the growth and success of the companies they have worked for.

Pierre d'Epenoux completed their education in International Trade & Finance from Advancia, Paris Chamber of Commerce and Industry, between 1989 and 1992. Additionally, in 1991 and 1992, they attended Drexel University to further study International Trade.